Among the most popular portfolio startups of the fund, we may highlight F2G. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Genetics.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2008.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the K Nominees, startups are often financed by Astellas Venture Management, Merifin Capital, BankInvest Biomedical Venture. The meaningful sponsors for the fund in investment in the same round are Merifin Capital, Astellas Venture Management, Sunstone Life Science Ventures. In the next rounds fund is usually obtained by Sunstone Life Science Ventures, Novartis Venture Fund, Merifin Capital.
Related Funds
| Fund Name | Location |
| Aurum Ventures | India, Maharashtra, Mumbai |
| Beijing Allcure Medical Technology | Beijing, Beijing, China |
| Efficient Capacity LLC | Belvedere Tiburon, California, United States |
| Level Equity | New York, New York, United States |
| Nummorum | Distrito Federal, Mexico, Mexico City |
| Shuangta Shipin | China, Japan, Kagoshima Prefecture |
| Taiwan Surface Mounting Technology | Taitung County, Taiwan, Taoyüan |
| Tongdu Capital | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 